Laser Systems in Georgia

Emvera Technologies, LLC is a FDA-registered, ISO 13485-compliant manufacturer of aesthetic and medical laser equipment serving dermatology and aesthetic medicine practitioners. Specializing in multi-wavelength diode lasers, intense pulsed light (IPL) systems, and fractionated CO2 lasers, Emvera provides solutions for hair removal, skin resurfacing, skin renewal, tattoo removal, vascular lesion treatment, and pigmentation correction. The company differentiates itself through a customer-centric business model featuring competitive pricing (approximately 50% below industry competitors), transferable warranties, 30-day buy-back programs, waived resell fees, reasonably priced spare parts, minimal consumables, lifetime customer service and training support, and flexible financing options. All equipment incorporates advanced features such as sapphire cooling technology for patient comfort. With over 25 years of industry experience, Emvera emphasizes transparency, reliability, and long-term partnership with healthcare providers and aesthetic practitioners.

Xstrahl is a global medical device manufacturer specializing in superficial and orthovoltage X-ray radiation therapy systems for clinical and preclinical research applications. The company delivers non-invasive radiation therapy equipment designed to treat non-melanoma skin cancers (basal cell and squamous cell carcinoma), benign dermatological conditions (keloid scarring, Dupuytren's contracture, Ledderhose disease), and palliative care indications. Xstrahl's clinical product line includes the Xstrahl 100, 150, 200, and 300 systems, along with the newer Radiant Aura platform with XBeam treatment planning software. These devices enable office-based and clinic-based treatment delivery by radiation oncologists and dermatologists with treatment outcomes comparable to surgical alternatives. The company also offers radiation research systems for translational research, enabling life science investigators, radiation physicists, and clinicians to conduct clinically relevant experiments. Xstrahl operates globally with North American headquarters in Suwanee, Georgia, and regional operations in the UK and Germany. The systems feature water-cooling technology, multiple energy levels (superficial and intermediate energies), user-friendly interfaces, and high reliability. Xstrahl supports the clinical and research community through educational resources, case studies, publications, presentations, and technical support services. The company positions itself as a leader in expanding access to non-invasive radiation therapy and advancing new treatment applications beyond traditional oncology.

IR Technology LLC (invisa-RED™) develops and manufactures FDA-cleared, non-invasive laser devices for aesthetic medical practices. The flagship invisa-RED ELITE system uses proprietary infrared and red laser technology to stimulate cellular respiration, lymphatic function, and ATP synthesis for clinically proven fat reduction, weight loss, and inch loss. The company also offers solutions for cellulite elimination, body contouring, and skin tightening. All devices are manufactured with medical-grade components and backed by a two-year warranty. IR Technology provides a comprehensive business model to aesthetic practices, including equipment supply, staff training, clinical protocols, and integrated marketing systems designed to drive patient acquisition and practice profitability. The company operates distribution networks across the United States, Mexico, Central America, and South America.

Remy Laser manufactures and distributes Class IV therapeutic laser systems for pain relief, wound healing, and dermatological applications. The company offers two primary product lines: the Remy™ (dual-wavelength 810nm/980nm) and the Remy™ FX (quad-wavelength 810nm/980nm/1064nm), both operating in continuous wave and repeat pulse modes. Indications include temporary relief of minor muscle and joint pain, arthritis pain, muscle spasms, increased local blood circulation, and muscle relaxation. The 980nm wavelength is indicated for podiatric soft tissue ablation, vaporization, incision, excision, and coagulation of periungual, subungual, and plantar warts. The 980nm is also indicated for temporary increase of clear nail in onychomycosis patients. Remy Laser positions itself on clinical effectiveness via photobiomodulation (PBM) technology—multi-wavelength near-infrared light that increases cellular ATP production, accelerates tissue healing, reduces pain and swelling, enhances circulation, and triggers immune response. The company emphasizes affordability, accessible financing, rapid practice integration, and comprehensive post-sale support including training, education, marketing resources, and responsive customer service. Target market includes podiatry, pain management, and physical therapy practices. Devices are restricted to sale by or on the order of a licensed physician and require proper clinical and technical training. Company provides ongoing educational webinars and practice support programs to help providers maximize clinical and financial outcomes.